DSPE-PEG(2000)-Amine structure
|
Common Name | DSPE-PEG(2000)-Amine | ||
|---|---|---|---|---|
| CAS Number | 474922-26-4 | Molecular Weight | 896.226 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | (C2H4O)nC44H87N2O10P.NH3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of DSPE-PEG(2000)-AmineDSPE-PEG(2000)-Amine is used in the synthesis of solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents[1][2][3]. |
| Name | 1,2-distearoyl-sn-glycero-3-phosphoethanolaMine-N-[aMino(polyethylene glycol)-2000] (aMMoniuM salt) |
|---|---|
| Synonym | More Synonyms |
| Description | DSPE-PEG(2000)-Amine is used in the synthesis of solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | DSPE-PEG(2000)-Amine is coated on the surface of the fluorescein diacetate (FDA) nanocrystals to provide a interface for the antibody coupling. The FDA[DSPE-PEG(2000)Amine]-modified biolabels have a highly stable colloidal suspension with minimized nonspecific interactions. The adsorbed DSPE-PEG(2000)Amine layer causes the FDA nanocrystals to disperse in water and prevents their aggregation, hence conferring colloidal stability[3]. |
| References |
| Molecular Formula | (C2H4O)nC44H87N2O10P.NH3 |
|---|---|
| Molecular Weight | 896.226 |
| Exact Mass | 895.662598 |
| Storage condition | -20°C |
| Hazard Class | 6.1 |
|---|
| Octadecanoic acid, 1-[[[[2-[[[2-(2-aminoethoxy)ethoxy]carbonyl]amino]ethoxy]hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, ammonium salt |
| 35-Amino-24-hydroxy-24-oxido-18,29-dioxo-19,23,25,30,33-pentaoxa-28-aza-24λ5-phosphapentatriacontan-21-yl octadecanoate ammoniate (1:1) |